Denintuzumab (hBU 12) 是一种重组人源化抗 CD19 单克隆抗体。Denintuzumab 可作为抗体偶联药物的抗体部分 (ADC antibody) 合成ADC，Denintuzumab Mafodotin (SGN-CD19A)。Denintuzumab Mafodotin 可用于急性淋巴细胞白血病的研究。
| 生物活性 | Denintuzumab (hBU 12) is a recombinanthumanized anti-CD19 monoclonal antibody. Denintuzumab can be used as the antibody moiety (ADC antibody) ofantibody-drug conjugatesto synthesize ADC, Denintuzumab Mafodotin (SGN-CD19A). Denintuzumab Mafodotin can be used in the research of acute lymphoblastic leukemia[1]. |
| IC50& Target | |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
